基蛋生物(603387.SH):董事孔婷婷超額減持股份致歉並承諾六個月內不減持
格隆匯9月28日丨基蛋生物(603387.SH)公佈,截至公吿披露日,公司董事孔婷婷直接持有公司股票59.903萬股,佔公司總股本363,813,302 股的0.1647%。上述股份來源於首次公開發行前持有的股份及上市後以資本公積轉增股本方式取得的股份。
公司於近日收到董事孔婷婷發來的《關於減持股份計劃實施結果的吿知函》。截至2021年9月28日,孔婷婷通過集中競價交易方式累計減持公司股份19.9669萬股,佔公司總股本的0.0549%,孔婷婷本次減持計劃實施完畢。
超額減持股份情況及致歉説明:公司於2021年9月28日收到孔婷婷出具的《基蛋生物科技股份有限公司股東及董監高減持結果吿知函》及《關於超額減持公司股票的情況説明及致歉聲明》,孔婷婷的減持計劃為擬減持不超過19.9萬股,因減持時在交易軟件上操作失誤,致使實際減持數量為19.9669萬股,超出減持計劃669股。孔婷婷對本次誤操作行為進行了深刻反省,其對給公司帶來的負面影響深表歉意,對廣大投資者致以誠摯的道歉。
孔婷婷自願將此次超額減持交易款即人民幣12456.78元全額上繳公司,作為對上述超額減持行為的處罰和補償,並承諾在未來六個月內不減持其持有的基蛋生物股份。公司將以此為戒,進一步加強組織實際控制人、持有5%以上股份的股東、董事、監事、高級管理人員再次認真學習相關法律法規、規範性文件,並要求相關人員及其親屬嚴格遵守有關規定,防止此類事件再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.